Lucid Diagnostics
Stock Forecast, Prediction & Price Target
Lucid Diagnostics (LUCD) stock Price Target by analysts
$2.5
Potential upside: 147.52%
Lucid Diagnostics price prediction
What is Lucid Diagnostics stock analysts` prediction?
Lucid Diagnostics stock forecast: Based on 1 Wall Street analysts` predicted price targets for Lucid Diagnostics in the last 3 months, the avarage price target is $2.5, with a high forecast of $NaN. The average price target represents a 147.52% change from the last price of $1.01.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Lucid Diagnostics stock Price Target by analysts
Full breakdown of analysts given Lucid Diagnostics price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Mike Matson Needham | 0% 0/1 | 10 months ago | $2.5 147.52% upside | $0.79 | StreetInsider | Previous targets (0) |
Kyle Mikson Canaccord Genuity | 0% 0/1 | over 1 year ago | $3 197.02% upside | $0.95 | StreetInsider | Previous targets (0) |
Mark Massaro BTIG | 0% 0/1 | over 1 year ago | $2.5 147.52% upside | $0.93 | StreetInsider | Previous targets (0) |
Unknown BTIG | N/A | almost 3 years ago | $3.5 246.53% upside | $1.91 | Benzinga | N/A |
Unknown Needham | N/A | almost 3 years ago | $3.1 206.93% upside | $2.27 | Benzinga | N/A |
Ross Osborn Cantor Fitzgerald | 0% 0/1 | over 3 years ago | $12 1088.11% upside | $2.46 | TipRanks Contributor | Previous targets (0) |
Lucid Diagnostics Financial Estimates
Lucid Diagnostics Revenue Estimates
Lucid Diagnostics EBITDA Estimates
Lucid Diagnostics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $500K N/A | $377K -24.6% | $2.42M 544.03% | Avg: $15.92M Low: $7.18M High: $37.45M avg. 555.99% | Avg: $49.24M Low: $27.13M High: $103.43M avg. 209.20% | Avg: $33.5M Low: $18.46M High: $70.35M avg. -31.97% | Avg: $51.6M Low: $28.43M High: $108.37M avg. 54.02% |
Net Income
% change YoY
| $-28.73M N/A | $-56.17M -95.46% | $-52.66M 6.23% | Avg: $-39.19M Low: $-42.17M High: $-23.38M avg. 25.57% | Avg: $-25.02M Low: $-32.98M High: $5.01M avg. 36.15% | Avg: $-22.96M Low: $-55.81M High: $-9.56M avg. 8.22% | Avg: $-18.37M Low: $-44.65M High: $-7.65M avg. 19.99% |
EBITDA
% change YoY
| $-27.41M N/A | $-54.23M -97.82% | $-49.75M 8.26% | Avg: $-3.18M Low: $-7.49M High: $-1.43M avg. 93.59% | Avg: $-9.84M Low: $-20.68M High: $-5.42M avg. -209.20% | Avg: $-6.69M Low: $-14.07M High: $-3.69M avg. 31.97% | Avg: $-10.31M Low: $-21.67M High: $-5.68M avg. -54.02% |
EPS
% change YoY
| -$0.82 N/A | -$1.55 -89.02% | -$1.26 18.70% | Avg: -$0.79 Low: -$1.01 High: -$0.56 avg. 37.61% | Avg: -$0.43 Low: -$0.79 High: $0.12 avg. 45.29% | Avg: -$0.55 Low: -$1.34 High: -$0.23 avg. -27.90% | Avg: -$0.44 Low: -$1.07 High: -$0.18 avg. 20.00% |
Operating Expenses
% change YoY
| $27.33M N/A | $52.93M 93.65% | $42.43M -19.83% | Avg: $503.90M Low: $227.42M High: $1.18B avg. 1087.56% | Avg: $1.55B Low: $858.61M High: $3.27B avg. 209.20% | Avg: $1.05B Low: $584.04M High: $2.22B avg. -31.97% | Avg: $1.63B Low: $899.60M High: $3.42B avg. 54.02% |
FAQ
What is Lucid Diagnostics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 22.48% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -42.17M, average is -39.19M and high is -23.38M.
What is Lucid Diagnostics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 196.81% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $7.18M, average is $15.92M and high is $37.45M.
What is Lucid Diagnostics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 18.75% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$1.01, average is -$0.79 and high is $-0.56.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Lucid Diagnostics stock. The most successful analyst is Mike Matson.